A major fraction of glycosphingolipids in model and cellular cholesterol-containing membranes is undetectable by their binding proteins.
Glycosphingolipids (GSLs) accumulate in cholesterol-enriched cell membrane domains and provide receptors for protein ligands. Lipid-based "aglycone" interactions can influence GSL carbohydrate epitope presentation. To evaluate this relationship, Verotoxin binding its receptor GSL, globotriaosyl ceramide (Gb(3)), was analyzed in simple GSL/cholesterol, detergent-resistant membrane vesicles by equilibrium density gradient centrifugation. Vesicles separated into two Gb(3/)cholesterol-containing populations. The lighter, minor fraction (<5% total GSL), bound VT1, VT2, IgG/IgM mAb anti-Gb(3), HIVgp120 or Bandeiraea simplicifolia lectin. Only IgM anti-Gb(3), more tolerant of carbohydrate modification, bound both vesicle fractions. Post-embedding cryo-immuno-EM confirmed these results. This appears to be a general GSL-cholesterol property, because similar receptor-inactive vesicles were separated for other GSL-protein ligand systems; cholera toxin (CTx)-GM1, HIVgp120-galactosyl ceramide/sulfatide. Inclusion of galactosyl or glucosyl ceramide (GalCer and GlcCer) rendered VT1-unreactive Gb(3)/cholesterol vesicles, VT1-reactive. We found GalCer and GlcCer bind Gb(3), suggesting GSL-GSL interaction can counter cholesterol masking of Gb(3). The similar separation of Vero cell membrane-derived vesicles into minor "binding," and major "non-binding" fractions when probed with VT1, CTx, or anti-SSEA4 (a human GSL stem cell marker), demonstrates potential physiological relevance. Cell membrane GSL masking was cholesterol- and actin-dependent. Cholesterol depletion of Vero and HeLa cells enabled differential VT1B subunit labeling of "available" and "cholesterol-masked" plasma membrane Gb(3) pools by fluorescence microscopy. Thus, the model GSL/cholesterol vesicle studies predicted two distinct membrane GSL formats, which were demonstrated within the plasma membrane of cultured cells. Cholesterol masking of most cell membrane GSLs may impinge many GSL receptor functions.
Mahfoud
Radhia
R
Division of Molecular Structure and Function, Research Institute, The Hospital for Sick Children, Ontario M5G 1X8, Canada.
Manis
Adam
A
Binnington
Beth
B
Ackerley
Cameron
C
Lingwood
Clifford A
CA
D000818:Animals; D002462:Cell Membrane / Q000737:chemistry / Q000378:metabolism* / Q000648:ultrastructure; D002522:Chlorocebus aethiops; D002772:Cholera Toxin / Q000378:metabolism; D002784:Cholesterol / Q000378:metabolism*; D020285:Cryoelectron Microscopy; D005677:G(M1) Ganglioside / Q000031:analogs & derivatives / Q000378:metabolism; D006028:Glycosphingolipids / Q000378:metabolism*; D015699:HIV Envelope Protein gp120 / Q000378:metabolism; D006801:Humans; D015151:Immunoblotting; D008856:Microscopy, Fluorescence; D016253:Microscopy, Immunoelectron; D011485:Protein Binding; D022603:Shiga Toxins / Q000378:metabolism*; D014281:Trihexosylceramides / Q000378:metabolism; D014709:Vero Cells
D006028:Glycosphingolipids; D015699:HIV Envelope Protein gp120; D022603:Shiga Toxins; D014281:Trihexosylceramides; C502266:ganglioside GM1alpha; D005677:G(M1) Ganglioside; C018549:globotriaosylceramide; D002772:Cholera Toxin; D002784:Cholesterol